Etsurou Watanabe

400 total citations
6 papers, 296 citations indexed

About

Etsurou Watanabe is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Etsurou Watanabe has authored 6 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Etsurou Watanabe's work include Steroid Chemistry and Biochemistry (4 papers), Cholesterol and Lipid Metabolism (3 papers) and Hormonal Regulation and Hypertension (3 papers). Etsurou Watanabe is often cited by papers focused on Steroid Chemistry and Biochemistry (4 papers), Cholesterol and Lipid Metabolism (3 papers) and Hormonal Regulation and Hypertension (3 papers). Etsurou Watanabe collaborates with scholars based in Japan and United States. Etsurou Watanabe's co-authors include Kai Liu, Hironori Kokubo, William Farnaby, Maki Miyamoto, Takanobu Kuroita, Masato Yoshikawa, Jason K. Yano, Tatsuki Koike, Toshiya Nishi and Tsuyoshi Ishii and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Etsurou Watanabe

5 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Etsurou Watanabe Japan	5	142	83	53	43	41	6	296
David Méndez-Luna Mexico	11	172 1.2×	68 0.8×	48 0.9×	37 0.9×	31 0.8×	24	360
Chinmoy Banerjee India	11	214 1.5×	30 0.4×	60 1.1×	28 0.7×	59 1.4×	18	462
Shubhra Jyoti Saha India	9	142 1.0×	29 0.3×	77 1.5×	22 0.5×	33 0.8×	14	352
Shiladitya Nag India	9	179 1.3×	27 0.3×	55 1.0×	25 0.6×	33 0.8×	15	352
Lauren B. Arendse South Africa	9	150 1.1×	77 0.9×	23 0.4×	32 0.7×	14 0.3×	11	417
Evan B. Smith United States	12	139 1.0×	46 0.6×	41 0.8×	64 1.5×	120 2.9×	13	379
Anna Furimsky United States	10	153 1.1×	27 0.3×	82 1.5×	26 0.6×	36 0.9×	18	439
Mette Guldbrandt Denmark	8	159 1.1×	68 0.8×	74 1.4×	43 1.0×	13 0.3×	9	365
Mridula Saxena India	10	177 1.2×	98 1.2×	119 2.2×	24 0.6×	21 0.5×	25	443
Muhammad Akram Pakistan	10	126 0.9×	102 1.2×	52 1.0×	26 0.6×	50 1.2×	27	319

Countries citing papers authored by Etsurou Watanabe

Since Specialization

Citations

This map shows the geographic impact of Etsurou Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etsurou Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etsurou Watanabe more than expected).

Fields of papers citing papers by Etsurou Watanabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Etsurou Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Etsurou Watanabe. The network helps show where Etsurou Watanabe may publish in the future.

Co-authorship network of co-authors of Etsurou Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Etsurou Watanabe. A scholar is included among the top collaborators of Etsurou Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Etsurou Watanabe. Etsurou Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

ITO, Y., Eiji Kimura, Izumi Nomura, et al.. (2025). Design and identification of brain-penetrant, potent, and selective 1,3-oxazole-based cholesterol 24-hydroxylase (CH24H) inhibitors. Bioorganic & Medicinal Chemistry. 124. 118182–118182.

2.

Kajita, Y., Shuhei Ikeda, Masato Yoshikawa, et al.. (2022). Discovery of Novel 3-Piperidinyl Pyridine Derivatives as Highly Potent and Selective Cholesterol 24-Hydroxylase (CH24H) Inhibitors. Journal of Medicinal Chemistry. 65(4). 3343–3358. 8 indexed citations

3.

Koike, Tatsuki, Masato Yoshikawa, William Farnaby, et al.. (2021). Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H). Journal of Medicinal Chemistry. 64(16). 12228–12244. 36 indexed citations

4.

Nishi, Toshiya, Shinichi Kondo, Maki Miyamoto, et al.. (2020). Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice. Scientific Reports. 10(1). 17081–17081. 61 indexed citations

5.

Liu, Kai, Etsurou Watanabe, & Hironori Kokubo. (2017). Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations. Journal of Computer-Aided Molecular Design. 31(2). 201–211. 172 indexed citations

6.

Katoh, Taisuke, Takafumi Takai, Tetsuya Tsukamoto, et al.. (2016). Discovery and optimization of 1,7-disubstituted-2,2-dimethyl-2,3-dihydroquinazolin-4(1H)-ones as potent and selective PKCθ inhibitors. Bioorganic & Medicinal Chemistry. 24(11). 2466–2475. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact